Valion Bio, Inc. Common Stock

VBIO XNAS • ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

2.1M

Short interest (May 15)

6.5%

Net Short (Jun 03 ): 0.3%

Borrow Fee

12.63%

↓ 5.6%

Available Shares

200K

↑ 28.6%

Price Chart

Company Overview

Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.

Company Info

Exchange: NASDAQ

Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

CIK: 0001787740

Asset Type: CS

Market Data

Market Cap: $2,101,981

Employees: 52

Status: Active

Short Interest

Current Borrow Fee 12.63%

Range: 12.62% - 12.64%

Available Shares 200K

Range: 50K - 150K

Recent Changes

Fee Change: ↓ 1.2%

Available Change: ↓ 0.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime